BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38649439)

  • 1. Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma.
    Heberle A; Cappuccio E; Andric A; Kuen T; Simonini A; Weiss AKH
    Sci Rep; 2024 Apr; 14(1):9231. PubMed ID: 38649439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) as a novel mitochondrial acylpyruvase.
    Pircher H; Straganz GD; Ehehalt D; Morrow G; Tanguay RM; Jansen-Dürr P
    J Biol Chem; 2011 Oct; 286(42):36500-8. PubMed ID: 21878618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of oxaloacetate decarboxylase FAHD1 inhibits mitochondrial electron transport and induces cellular senescence in human endothelial cells.
    Petit M; Koziel R; Etemad S; Pircher H; Jansen-Dürr P
    Exp Gerontol; 2017 Jun; 92():7-12. PubMed ID: 28286170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT-20 cells in vitro.
    Holzknecht M; Guerrero-Navarro L; Petit M; Albertini E; Damisch E; Simonini A; Schmitt F; Parson W; Fiegl H; Weiss A; Jansen-Duerr P
    FEBS Lett; 2022 Nov; 596(21):2781-2794. PubMed ID: 35962472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional comparison of fumarylacetoacetate domain containing protein 1 in human and mouse.
    Weiss AKH; Naschberger A; Cappuccio E; Metzger C; Mottes L; Holzknecht M; von Velsen J; Bowler MW; Rupp B; Jansen-Dürr P
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32068790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaloacetate decarboxylase FAHD1 - a new regulator of mitochondrial function and senescence.
    Etemad S; Petit M; Weiss AKH; Schrattenholz A; Baraldo G; Jansen-Dürr P
    Mech Ageing Dev; 2019 Jan; 177():22-29. PubMed ID: 30055189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Fumarylacetoacetate Hydrolase Domain Containing Protein 1 (FAHD1).
    Weiss AKH; Wurzer R; Klapec P; Eder MP; Loeffler JR; von Grafenstein S; Monteleone S; Liedl KR; Jansen-Dürr P; Gstach H
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443596
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.
    Weiss AKH; Naschberger A; Loeffler JR; Gstach H; Bowler MW; Holzknecht M; Cappuccio E; Pittl A; Etemad S; Dunzendorfer-Matt T; Scheffzek K; Liedl KR; Jansen-Dürr P
    Biochem J; 2018 Nov; 475(22):3561-3576. PubMed ID: 30348641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
    Dai G; Zheng D; Guo W; Yang J; Cheng AY
    Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
    Zhao Z; Sun Y; Tang J; Yang Y; Xu X
    BMC Cancer; 2023 Oct; 23(1):935. PubMed ID: 37789316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
    Xu Z; Choudhary S; Voznesensky O; Mehrotra M; Woodard M; Hansen M; Herschman H; Pilbeam C
    Cancer Res; 2006 Jul; 66(13):6657-64. PubMed ID: 16818639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Glycolytic Activity Enhances Stem Cell Reprogramming of Fahd1-KO Mouse Embryonic Fibroblasts.
    Salti A; Etemad S; Cubero MS; Albertini E; Kovacs-Szalka B; Holzknecht M; Cappuccio E; Cavinato M; Edenhofer F; Jansen Dürr P
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artocarpin induces cell apoptosis in human osteosarcoma cells through endoplasmic reticulum stress and reactive oxygen species.
    Lee CW; Chi MC; Chang TM; Liu JF
    J Cell Physiol; 2019 Aug; 234(8):13157-13168. PubMed ID: 30549031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma.
    Wang Z; Yin F; Xu J; Zhang T; Wang G; Mao M; Wang Z; Sun W; Han J; Yang M; Jiang Y; Hua Y; Cai Z
    J Exp Clin Cancer Res; 2019 Jan; 38(1):44. PubMed ID: 30704503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of FAH domain-containing protein 1 (FAHD1) as oxaloacetate decarboxylase.
    Pircher H; von Grafenstein S; Diener T; Metzger C; Albertini E; Taferner A; Unterluggauer H; Kramer C; Liedl KR; Jansen-Dürr P
    J Biol Chem; 2015 Mar; 290(11):6755-62. PubMed ID: 25575590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of radiation damage of U2OS osteosarcoma cells is related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity.
    Tang X; Yuan F; Guo K
    Mol Cell Biochem; 2014 May; 390(1-2):51-9. PubMed ID: 24390088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress induced by low-dose doxorubicin promotes the invasiveness of osteosarcoma cell line U2OS in vitro.
    Shin SH; Choi YJ; Lee H; Kim HS; Seo SW
    Tumour Biol; 2016 Feb; 37(2):1591-8. PubMed ID: 26298721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the value of mitochondrial associated protein fumarylacetoacetate domain containing protein 1 and growth differentiation factor-15 in the diagnosis of sepsis: test results from the patients of a multicenter study].
    Li M; Ren R; Chen S; Chen C; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):180-185. PubMed ID: 33729137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect and Mechanism of
    Li X; Liu LF; Liu YZ; Pan YT; Li G; Lu QY; Li ZC
    Balkan Med J; 2018 Mar; 35(2):155-162. PubMed ID: 29363485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.